what is the rate limiting amino acid in glutathione Derivatives: Neurotransmitters, Nitric Oxide, and More Glutathione Homeostasis and Functions: Potential
Description
Elevated intracellular GSH levels represent both a barrier to conventional therapies and an opportunity to design redox-responsive drug delivery systems
Individual response, tolerability and IGF-1 kinetics vary, and any research program should include baseline and follow-up laboratory monitoring
Traditional oral glutathione supplements struggled with poor absorption though newer delivery systems, like liposomal formulations and transdermal serums, may offer reliable systemic uptake and consistent dosing without the need for injections
10.1016/0009-8981(86)90118-x 77 KakutaK.OrinoK.YamamotoS.WatanabeK
No human clinical trial adverse-event data is available for IGF-1 LR3 specifically
